Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroblastoma 9 Ganglioneuroblastoma 5 Wilms Tumor 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Medulloblastoma 1 Kidney Neoplasms 1

Interventions

pembrolizumab 14 Nivolumab 11 Ipilimumab 10 cabozantinib 6 Axitinib 6 belzutifan 5 Radiosurgery 5 atezolizumab 4 Sunitinib 4 palbociclib 3 lenvatinib 3 Surveys and Questionnaires 3 Radiotherapy 3 Pluvicto 3 Everolimus 3 Blood Specimen Collection 3 Biopsy 3 zimberelimab 2 pazopanib 2 cemiplimab 2 Therapeutics 2 Methods 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 trebananib 1 toripalimab 1 tocilizumab 1 temsirolimus 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Isotretinoin × 1 year × Clear all

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡